Jan 012025
Drug Name |
Active Ingredient(s) |
Approval Date |
FDA-Approved Use on Approval Date |
Press Release |
Drug Trials Snapshot |
| Alhemo | concizumab-mtci | 12/20/2024 | For routine prophylaxis to prevent bleeding episodes in hemophilia A and B | ||
| Alyftrek | vanzacaftor, tezacaftor, and deutivacaftor | 12/20/2024 | To treat cystic fibrosis | ||
| Tryngolza | olezarsen | 12/19/2024 | To treat familial chylomicronemia syndrome | ||
| Ensacove | ensartinib | 12/18/2024 | To treat non-small cell lung cancer | ||
| Crenessity | crinecerfont | 12/13/2024 | To treat classic congenital adrenal hyperplasia | Press Release | |
| Unloxcyt | cosibelimab-ipdl | 12/13/2024 | To treat cutaneous squamous cell carcinoma | ||
| Bizengri | zenocutuzumab-zbco | 12/4/2024 | To treat non-small cell lung cancer and pancreatic adenocarcinoma |
Sorry, the comment form is closed at this time.